Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients.
BACKGROUND
Nephrotic syndrome (NS) is characterized by profound changes in albumin and fibrinogen levels. Dietary protein restriction has been advocated in the treatment of patients with NS, but its effects on albumin and fibrinogen metabolism have not been fully elucidated.


METHODS
We evaluated the effects of dietary protein restriction on endogenous leucine flux (ELF), fibrinogen and albumin metabolism in seven patients with NS who consumed either a normal protein diet (NPD; 1.20 +/- 0.06 g/kg/day), or a low protein diet (LPS; 0.66 +/- 0.04 g/kg/day) for four weeks. Seven normal subjects served as controls. The postabsorptive ELF value, fractional synthesis rate (FSR) and absolute synthesis rate (ASR) of both albumin and fibrinogen were evaluated during the last 120 minutes of a five-hour 5,5,5-D3-L-leucine infusion.


RESULTS
During the NPD regimen. ELF was increased, serum albumin was reduced, plasma fibrinogen was increased, albumin FSR and ASR were both increased, fibrinogen FSR was normal, and fibrinogen ASR was greater in patients with NS compared to controls. In patients with NS the LPD regimen reduced proteinuria, ELF, albumin FSR and ASR, plasma fibrinogen levels, fibrinogen ASR, and increased serum ulbumin levels. Dietary-induced changes in albumin and fibrinogen synthesis were significantly correlated (r = 0.719, P < 0.05).


CONCLUSIONS
Patients with NS treated with LPD show: (1) a reduction of proteinuria, albumin ASR and FSR, with an increase in serum albumin levels and its intravascular pool; (2) a decrease of fibrinogen ASR, with a reduction in both plasma fibrinogen levels and intravascular pool; and (3) a reduced rate of whole body proteolysis.
Giordano
M
M
Istituto di Clinica Medica "L. Condorelli," University of Catania, Catania, Italy. giordmau@tin.it
De Feo
P
P
Lucidi
P
P
DePascale
E
E
Giordano
G
G
Cirillo
D
D
Dardo
G
G
Signorelli
S S
SS
Castellino
P
P
D000328:Adult; D004044:Dietary Proteins / Q000008:administration & dosage*; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis*; D006801:Humans; D007930:Leucine / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood* / Q000178:diet therapy* / Q000503:physiopathology; D009752:Nutritional Status; D012709:Serum Albumin / Q000096:biosynthesis*
D004044:Dietary Proteins; D012709:Serum Albumin; D005340:Fibrinogen; D007930:Leucine